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ABSTRAK
Tujuan: pengaruh nilai indeks aterogenik plasma (IAP) yang dihitung dari rumus logaritme rasio 
trigliserid:HDL (log10.[TG:HDL]) terhadap kejadian kardiovaskular mayor selama perawatan infark miokard 
akut (IMA) belum sepenuhnya disepakati. Penelitian ini bertujuan mengetahui peran IAP dalam memprediksi 
kejadian kardiovaskular mayor selama perawatan IMA. Metode: penelitian ini merupakan studi kohort 
prospektif. Subjek merupakan pasien IMA yang dirawat di perawatan intensif koroner RSUP Dr. Sardjito, 
Yogyakarta. Nilai IAP diukur dari darah puasa dalam 24 jam admisi rumah sakit. Kolesterol total, LDL, HDL, 
dan trigliserida (TG) diukur dan nilai IAP ditentukan dengan rumus log10. [TG:HDL]. Berdasarkan nilai IAP, 
subjek dialokasikan menjadi IAP rendah (<0,24) dan IAP tinggi (≥0,24). Luaran penelitian ini adalah kejadian 
kardiovaskular mayor selama perawatan intensif yang berupa kumpulan dari kematian semua sebab, gagal 
jantung akut, syok kardiogenik, kejadian re-infark, dan VT/VF yang diresusitasi. Hasil: sebanyak 277 subjek 
direkrut dalam penelitian ini. Grup IAP tinggi terdiri dari 213 subjek (77%) dan grup IAP rendah terdiri dari 
64 subjek (33%). Selama perawatan intensif, 66 subjek (24%) mengalami kejadian kardiovaskular mayor dan 
20 (7%) subjek meninggal dunia (kematian semua sebab). Insidens kejadian kardiovaskular mayor cenderung 
lebih besar pada kelompok IAP rendah, meskipun tidak bermakna secara statistik. Insidens kematian semua 
sebab secara bermakna lebih tinggi pada kelompok IAP rendah (14%) dibandingkan IAP tinggi (5%). Analisis 
multivariat menunjukkan bahwa IAP rendah memprediksi secara independen kematian semua sebab dengan 
rasio risiko 3,71 (95% CI 1,26–10,97, nilai p=0,02). Kesimpulan: nilai IAP rendah (<0,24) merupakan prediktor 
independen kematian semua sebab selama perawatan intensif pada pasien infark miokard akut.
Kata kunci: lipid aterogenik, indeks aterogenik plasma, kejadian kardiovaskular mayor, kematian.
ABSTRACT
Aim: the impact of atherogenic index of plasma (AIP), calculated as logarithmic of triglyceride:HDL 
ratio (log10.[TG:HDL]), on major adverse cardiovascular events (MACE) during acute myocardial infarction 
(AMI) has not been fully accepted. This study aims to investigate the role of AIP in predicting major adverse 
cardiovascular events following AMI during intensive care in the hospital. Methods: this was a prospective 
cohort study. We enrolled subjects with AMI hospitalized in intensive coronary care unit at Dr. Sardjito General 
Hospital, Yogyakarta. The AIP was measured in fasting blood within 24 hours of hospital admission. The 
total cholesterol, LDL, HDL, and triglyceride (TG), were measured and AIP value was determined as log10.
[TG:HDL]). Based on AIP value, subjects were allocated into low AIP (<0.24) and high AIP (≥0.24). The 
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outcome of the study was major adverse cardiovascular events during hospitalization, i.e. multipart of all 
cause mortality, acute heart failure, cardiogenic shock, reinfarction, and rescucitated VT/VF. Results: among 
277 subjects, the high AIP group comprised 213 subjects (77%) and low AIP group comprised 64 subjects 
(33%). During intensive hospitalisation, 66 subjects (24%) developed MACE and 20 subjects (7%) developed 
fatal outcome (all cause mortality). The incidence of MACE tended to be higher in low AIP group, however its 
difference was not significant. The incidence of all cause mortality was significantly higher in low AIP group 
(14%) than in high AIP group (5%). Multivariable analysis showed that low AIP predicted all cause mortality 
independently with a risk ratio 3.71 (95% CI 1.26 – 10.97, p=0.02). Conclusion: low AIP value (<0.24) is an 
independent predictor for all cause mortality in patients with acute myocardial infarction undergoing intensive 
hospitalisation.
Keywords: atherogenic lipids, atherogenic index of plasma, major adverse cardiovascular events, mortality.
INTRODUCTION
The atherogenic lipid is the main risk factor 
for coronary artery disease. Atherogenic lipids 
drive the capability of plasma lipid in mediating 
atherosclerotic plaque formation in coronary 
artery. The ability of plasma lipid to migrate 
into the subintimal layer is an important step 
to developing atherosclerosis. Lipid and its 
lipoprotein constituent have been designated 
as a mediator and a marker of coronary heart 
disease. Several atherogenic lipids in the 
blood that have been identified are high level 
of LDL cholesterol, the high ratio of LDL 
cholesterol to HDL cholesterol and high level of 
triglyceride.1 Atherogenic lipoproteins that have 
been identified are the high apoliprotein B, low 
apolipoprotein A1 and the high ratio of apoB: 
apoA1.2,3 In addition to lipid and lipoprotein 
particles, the size of the lipid particles such as 
small dense LDL also affects the formation and 
progression of coronary atherosclerosis.3
Atherogenic plasma lipid is a reflection of the 
degrees of plasma atherogenicity. Atherogenic 
plasma lipid assessment can be used to as a 
marker that is simple and practical in daily 
clinical practice. Lipid examination has been 
widely used in the routine evaluation of patients 
at risk of cardiovascular disease in general 
and coronary heart disease in particular.4 The 
atherogenic index of plasma (AIP), developed 
from the 10 logarithmic ratio of triglyceride 
and HDL cholesterol level, was an indicator 
of smaller LDL particles and HDL fractional 
esterification rate that reflects the presence of 
atherosclerotic disease.5
Acute myocardial infarction (AMI) is a 
clinical spectrum of coronary heart disease 
that indicates the formation of acute occlusive 
thrombus in coronary atherosclerotic lesions. 
In patients with AMI, decreased levels of 
atherogenic plasma lipids, especially LDL 
cholesterol and apoB with statins treatment 
have shown positive results for the secondary 
prevention after myocardial infarction.6 In the 
short term, the impact of atherogenic plasma lipid 
during hospital care in AMI get less attention 
than its long term impact before and after the 
event. Patients with AMI are at risk of MACE 
that occurred both at admission and during 
hospital treatment. Our previous data show that 
about 45% of patients with AMI experienced 
MACE during hospitalisation.7,8 The role of AIP 
value in affecting major adverse cardiovascular 
events during hospitalisation in AMI is unclear 
because only few studies have been conducted 
and they showed conflicting results.
This study aims to investigate whether the 
AIP value associates with MACE, both fatal or 
non-fatal events during intensive hospitalization 
in patients with AMI. This study also investigated 
whether AIP value acts as a predictor of MACE 
in patients with AMI.
METHODS
This is a prospective cohort study. We 
enrolled consecutively, between August 2013 
and April 2015, patients with AMI admitted 
and hospitalized in the intensive coronary care 
unit (ICCU) at Dr. Sardjito General Hospital, 
Yogyakarta, Indonesia.
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Subjects
We included patients with inclusion criterias: 
(1) patients with AMI and diagnosed as ST-
segment elevation acute myocardial infarction 
(STEMI) and NSTEMI, based on ACC/AHA 
and ESC guideline criteria,9 (2) patients with an 
identifiable onset of anginal pain ≤24 hours with 
exception those with NSTEMI, (3) patients with 
age between 30 and 75 years old, and (4) patients 
agreed to participate in the study by signing an 
informed consent. We excluded patients who 
had exclusion criterias: (1) patients with known 
chronic heart failure, chronic kidney disease, 
liver cirrhosis, chronic inflammatory diseases, 
and malignancy, (2) patients with concomitant 
severe acute infection and sepsis, (3) patients 
with concomitant acute stroke, (4) patients 
taking regular antihyperlipidemic medication 
before admission, and (5) patients already 
revascularized (fibrinolysis) before admission. 
Variables
We  c o l l e c t e d  a n d  r e c o r d e d  t h e 
sociodemographic, risk factors, and clinical 
presentation data. Diabetes mellitus was 
determined as subjects with previously known 
diabetic or those taking antidiabetic medication 
on admission. Hypertension was determined as 
subjects with previously known hypertension 
or those taking antihypertensive medications or 
those with systolic blood pressure ≥150 mmHg 
and diastolic blood pressure ≥90 mmHg. Smoking 
was determined as having been smoking cigar 
and/or cigarettes within previous month until 
current event. Chronic heart  failure, chronic 
kidney disease, hepatic cirrhosis and malignancy 
were determined by history taking. Chronic 
inflammatory diseases, i.e. rheumatoid arthritis, 
inflammatory bowel disease or psoriasis, was 
also unravelled through history taking. Severe 
acute infection was determined as fever and 
known focal infection. Sepsis was determined 
based on standard criterias and confirmed by 
an internist in consultation. Acute stroke was 
determined as an infarct or hemorrhage stroke, 
confirmed by a neurologist. The diagnosis of 
STEMI and NSTEMI was in accordance with 
the criteria of ACCF/AHA and ESC.9
For laboratory examination, we collected 
the venous blood from the antecubital veins 
in supine position in every subject. Blood 
collection was performed on admission, before 
revascularisation, and anticoagulant therapy 
started, and after fasting in early morning. 
Routine blood cell counts, renal function 
and random glucose were measured using on 
admission sample with an automated blood cell 
counter and chemistry analyzer in the hospital 
laboratory. Blood samples for atherogenic plasma 
lipid measurement was taken using fasting blood 
sample (within 24 hours from admission). The 
lipid profiles were total cholesterol, low density 
liporotein (LDL) cholesterol, high density 
lipoprotein (HDL) cholesterol, and triglyceride 
(TG). They were measured with a chemistry 
analyzer in the hospital laboratory. The AIP was 
determined by calculation based on formula =10 
logarithmic of  [TG:HDL].5 Based on previous 
classification of AIP value10, we divided the 
subjects into two categories, which are low AIP 
(<0.24) and high AIP (≥0.24).
We monitored the clinical progression and 
treatment strategy of the subjects during intensive 
hospitalisation in ICCU. The outcome of the study 
is the incidence of major adverse cardiovascular 
events (MACE), which determined as multipart 
of all cause mortality, acute heart failure, 
cardiogenic shock, re-infarction, and rescucitated 
VT/VF. Fatal event was all cause mortality which 
was determined as death from all etiologies 
during intensive hospitalisation. Acute heart 
failure was defined as the presence of symptom 
of breathlesness and fatique with the signs of 
congestion and subsequent use of intravenous 
diuretics. Cardiogenic shock was termed as 
systolic blood pressure <90 mmHg and the 
signs of low perfusion with subsequent use of 
vasopressor (dopamine and norepinephrine). 
Reinfarction was defined as recurrent  chest 
pain, recurrent ST-segment elevation, and a 
recurrent elevation of creatine kinase-MB after 
subjects subsided clinically. Rescucitated VT/
VF was defined as an episode of defibrillation 
and cardiopulmonary rescucitation due to VT 
or VF. The confirmation of each item of MACE 
was finalized by attending cardiologists. All 
treatment of the subjects and related to the events 
were in the discretion of attending cardiologists. 
Uneventful discharge of subjects from ICCU 
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was determined as the end of observation. All 
subjects or familiy were participated voluntarily 
and confirmed an informed consent. The study 
had been approved by The Medical and Health 
Research Ethics Committee Faculty of Medicine 
Universitas Gadjah Mada and Dr. Sardjito 
General Hospital, Yogyakarta. 
Statistic Analysis
The subjects were allocated into two groups, 
which are low AIP and high AIP. The incidence 
of MACE were compared between two groups. 
Univariate and multivariable analysis were 
performed to explore the relationship between 
AIP value and MACE. p<0.05 was determined 
as statistical significancy.
RESULTS
The study enrolled 277 subjects consecutively. 
The mean AIP value was 0.43, median value was 
0.43 with minimum value -0.34 and maximum 
value 1.31. The high AIP group comprised 213 
subjects (77% of all subjects) and the low AIP 
group consisted of 64 (33% of all subjects). Table 
1 showed the comparison of each characteristic 
between subjects with high AIP and low AIP.
The AIP value has weak inversely correlation 
with age (r = -0.30, p<0.01), moderate inversely 
correlation with HDL cholesterol (r=-0.63, 
p<0.01), and strong correlation with triglyceride 
(r=0.79, p<0.01). Table 2 showed the correlation 
between AIP value with other continuous 
variables.
Table 1. Characteristics between subjects with high AIP 
and low AIP
Variables Low AIP(n=64)
High AIP
(n=213)
Demographic characteristics
 - Age (years), mean 
(SD) 61.9 (9.1) 56.6 (8.8)
 - Male sex, n (%) 50 (78) 171(80)
 - Body mass index, 
mean (SD) 23.4 (3.0) 23.9 (3.3)
Risk factors
 - Diabetes mellitus, 
n (%) 11 (17) 66 (31)
 - Hypertension, n (%) 39 (61) 134 (63)
 - Current smoking, 
n (%) 29 (45) 104 (49)
Table 1. Characteristics between subjects with high AIP 
and low AIP
Variables Low AIP(n=64)
High AIP
(n=213)
Clinical presentations
 - Systolic b.p 
(mmHg), mean (SD)
132.7 (22.0) 125.9 (26.1)
 - Heart rate (bpm), 
mean (SD)
73.5 (15.1) 80.0 (19.2)
 - Killip II-IV, n (%) 6 (9) 36 (17)
Laboratory, mean (SD)
 - Haemoglobin (g/dL) 13.5 (1.8) 13.7 (1.9)
 - Leucocytes (103/
mm3)
12.1 (4.1) 12.5 (4.2)
 - Platelets (103/mm3) 243.9 (71.6) 259.7 (84.4)
 - Blood urea nitrogen 
(mg/dL)
17.1 (8.3) 16.1 (7.8)
 - Creatinine (mg/dL) 1.2 (0.4) 1.2 (0.6)
 - Glucose (mg/dL) 177.6 (105.3) 188.9 (103.8)
 - Troponin I (ng/dL)* 8.8 (9.7) 6.5 (9.3)
 - Total cholesterol 
(mg/dL)
180.8 (48.2) 186.9 (44.7)
 - LDL cholesterol (mg/
dL)
110.0 (30.9) 126.9 (39.6)
 - HDL cholesterol 
(mg/dL)
60.5 (22.9) 40.0 (10.7)
 - Triglyceride (mg/dL) 69.9 (21.9) 144.4 (69.3)
Diagnosis
 - STEMI, n (%) 49 (77) 160 (75)
 - NSTEMI, n (%) 15(23) 53 (25)
Admission treatment
 - Primary PCI, n (%) 14 (22) 60 (28)
 - Fibrinolysis, n (%) 20 (31) 50 (24)
 - Heparinisation, n 
(%)
31 (48) 104 (49)
Coronary angiography**
 - 1 vessel disease 4 (6) 15 (7)
 - 2 vessel disease 6 (9) 20 (9)
 - 3 vessel disease 8 (13) 21 (10)
SD, standard deviation; AIP, atherogenic index of 
plasma;b.p, blood pressure; LDL, low density lipoprotein; 
HDL, high density lipoprotein; STEMI, ST elevation 
myocardial infarction; NSTEMI, Non ST elevation 
myocardial infarction; PCI, percutaneous coronary 
intervention.
* measured in 135 subjects,  ** performed in 74 subjects 
(primary PCI)
During intensive hospitalisation, 66 subjects 
(24%) developed MACE. Among those, 18 
(28%) were subjects with low AIP and 48 (23%) 
were subjects with high AIP. No significant 
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Using logistic regression analysis, the 
multivariable analysis was constructed to 
identify the independent predictors of all cause 
mortality. The result showed that low AIP was 
an independent predictor for all cause mortality 
in patients with AMI. The risk ratio of all cause 
mortality during hospitalisation in subjects with 
low AIP was 3.71 (95% CI 1.26 – 10.97, p value 
= 0.02). Table 4 showed the logistic regression 
analysis for independent predictors of all cause 
mortality.
DISCUSSION
The result of our study indicates that the 
value of AIP influences the clinical prognosis in 
the hospitalized patients with AMI. The patients 
with lower value of AIP, with cut-off value 0.24, 
had a trend toward higher risk to develop MACE 
Table 2. Correlation between AIP value with continuous 
variables from subjects characteristics on admission
Variables Coefficient correlation P value
Age - 0.30 <0.01
Body mass index 0.09 0.13
Systolic blood pressure 0.02 0.86
Heart rate 0.10 0.19
Haemoglobin (g/dL) 0.14 0.02
Leucocytes (103/mm3) -0.03 0.65
Platelets (103/mm3) 0.01 0.97
Blood urea nitrogen (mg/
dL)
- 0.07 0.27
Creatinine (mg/dL) 0.03 0.58
Glucose (mg/dL) 0.06 0.32
Troponin I (ng/dL) - 0.05 0.41
Total cholesterol (mg/dL) 0.03 0.59
LDL cholesterol (mg/dL) 0.17 <0.01
HDL cholesterol (mg/dL) - 0.63 <0.01
Triglyceride 0.79 <0.01
difference was detected on the incidence of 
MACE between two groups. A subgroup analysis, 
based on diagnosis of STEMI and NSTEMI, the 
incidence of MACE did not differ significantly, 
only a tendency toward higher incidence in the 
low AIP group between two spectra of diseases, 
especially in NSTEMI (Figure 1).
Subsequent analysis showed that the 
incidence of fatal events (7%), i.e. all cause 
mortality, was significantly higher in subjects 
with low AIP (9 out of 64 or 14%) than in 
those with high AIP (11 out of 213 or 5%) 
(Figure 2). Whereas the incidence of non fatal 
cardiovascular events was not significantly 
different (14% and 17%, respectively). Since the 
statistically significant difference was observed 
in the incidence of all cause mortality between 
groups, we further explore the association 
between covariables with all cause mortality.
The bivariate analysis to identify predictors 
of all cause mortality in all subjects resulted 
in several variables as potential predictors. 
Other than low AIP, these variables were age, 
diabetes mellitus, heart rate, Killip class II-IV, 
haemoglobin level, urea nitrogen level, creatinine 
level, and glucose level. Table 3 showed the 
bivariate analysis of potential predictors of fatal 
event.
Figure 1. The incidence of MACE was comparable between 
low AIP and high AIP groups with a tendency toward higher 
incidence in subject with low AIP both in STEMI (29% vs 
25%) and NSTEMI (27% vs 15%).
Figure 2. The incidence of fatal event, i.e. all cause mortality, 
was significantly higher in subjects with low AIP as compared 
to those with high AIP (14% v.s. 5%, p=0.02)
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parameters with AIP in patients with AMI. 
Coronary angiography, measuring the severity 
of coronary atherosclerosis and thrombosis, were 
comparable between low AIP subjects and those 
with high AIP.
The higher ratio of TG:LDL is an independent 
predictor of cardiovascular mortality from acute 
episode until 35 months follow-up patients with 
in acute coronary syndrome.12 Increased AIP 
value was a significant predictor of mortality 
events independent of age, gender, smoking, 
and diabetes. It remains predictive after adding 
coronary artery disease severity score.12 In 
contrast to a previous study, here we show that 
lower AIP, other than high AIP value, significantly 
and independently predict in-hospital mortality in 
AMI. The previous study enrolled acute coronary 
syndrome undergoing revascularisation, whereas 
in our current study not all subject undergo 
coronary revascularisation. Furthermore, all 
cause mortality was assessed in the long term 
(more than 30 months) in the previous study, 
which extent its finding that higher AIP predicts 
long term mortality after acute coronary 
syndrome.12 Our study assessed mortality and 
major adverse cardiovascular events only during 
hospitalisation, which was a critical period of 
time within acute cardiac care.
The level of plasma TG and HDL cholesterol 
have been used to predict coronary vascular 
disease risk in healthy population and worse 
prognosis after acute coronary syndrome. 
The logarithmic ratio of TG:HDL conveys 
more precise prediction as compared to single 
measurement of TG or HDL or the ratio of 
TG:HDL.5 Research indicates that 10 logarithmic 
of ratio TG:HDL closely correlates with LDL 
particle size and esterification rate in apoB-
lipoprotein-depleted plasma (FERHDL).5 The 
FERHDL is an indirect calculation of lipoprotein 
particle size, i.e. HDL and LDL particle size 
which are deemed strong atherogenic lipoprotein. 
The fastest FERHDL is found in the smallest 
HDL particles, whereas the slowest is found 
in larger HDL particles.13 Furthermore, high 
FERHDL and AIP value is higher in individual 
suffering from myocardial infarction.14,15 The AIP 
reflects a balance between plasma TG and HDL 
cholesterol level in actual value which determine 
Table 3. Bivariate analysis of potential predictors for all 
cause mortality
Variables Risk Ratio (95% CI) P value
Age 1.05 (0.99 – 1.10) 0.10
Diabetes mellitus 2.84 (1.13 – 7.11) 0.03
Heart rate 1.03 (0.99 – 1.05) 0.11
Killip II-IV 3.42 (1.28 – 9.15) 0.01
Haemoglobin 0.86 (0.68 – 1.08) 0.19
Blood urea nitrogen 1.07 (1.03 – 1.12) 0.01
Creatinine 1.48 (0.86 – 2.54) 0.16
Glucose 1.01 (1.00 – 1.02) 0.01
Low AIP 3.01 (1.19 – 7.62) 0.02
and significant increased in fatal event, i.e. all 
cause mortality, as compared to those with higher 
value of AIP. The risk of death during intensive 
hospitalisation was almost 4-fold higher in 
patients with low AIP. This was the first time 
evidence to report the impact of low AIP value 
on in-hospital mortality in patients with AMI.
The result of our study is rather surprising in 
which the low AIP value, rather than high AIP, 
independently predicts in-hospital mortality in 
AMI, both for STEMI and NSTEMI. It signifies 
the role of AIP in the pathogenesis of acute 
myocardial infarction. Hypertriglyceridemia and 
low HDL level increased the risk of coronary 
heart disease and its subsequent complication, 
such as acute coronary syndrome. Patients with 
hypertriglyceridemia and low HDL associate 
with other components of metabolic syndrome, 
i.e. increased body mass index, hypertension 
and elevated glucose level.11 However, our 
study indicates no correlation between those 
Table 4. Multivariable analysis for independent predictors 
of all cause mortality
Variables Adjusted Risk Ratio (95% CI) P value
Age 1.04 (0.98 – 1.10) 0.23
Diabetes mellitus 1.98 (0.63 – 6.17) 0.24
Heart rate 1.02 (0.99 – 1.05) 0.26
Killip II-IV 2.27 (0.72 – 7.14) 0.16
Haemoglobin 0.96 (0.74 – 1.25) 0.78
Blood urea nitrogen 1.06 (0.99 – 1.13) 0.09
Creatinine 0.89 (0.36 – 2.19) 0.81
Glucose 1.00 (0.99 – 1.01) 0.12
Low AIP 3.71 (1.26 – 10.97) 0.02
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the course of cholesterol transport in circulation.5
Our study showed that AIP value negatively 
correlated with years of age. It means the older 
the patients, the lower the AIP value. This finding 
corroborated other studies which revealed 
similar observation.16,17 The correlation markedly 
significant especially in male individuals.16 
Age is a significant predictor for morbidity 
and mortality following acute intensive care 
in patients with acute myocardial infarction. 
However, multivariable analysis showed that 
age do not predict the incidence of in-hospital 
mortality. In our cohort of patients, low AIP 
group comprised older age as compared to high 
AIP group, whereas the gender was comparable 
of male predominance. The explanation as to 
why low AIP increased the risk of mortality 
remains elusive. The role of dietary intake is a 
promising explanation, since our subjects mostly 
came from suburban area with low fat and high 
fiber diet which may affect the trygliceride and 
HDL level. This speculative hypothesis needs to 
be corroborated.
Some limitations of this study were as 
follow: (1) the number of subjects with fatal 
events (i.e. all cause mortality) was small, 
therefore the precision of the result was low, (2) 
the lack of mechanism as to why AIP influenced 
acute coronary events should be explored, and 
(3) the data of previous medication that may 
influence plasma lipid were not available.
CONCLUSION
A low AIP value (<0.24) is an independent 
predictor for mortality in patients with AMI 
undergoing intensive hospitalisation. A low AIP 
value had a tendency toward higher incidence of 
major adverse cardiovascular events (MACE), 
but no statistical significance was found. Further 
study is encouraged to corroborate this finding 
and investigate the clinical mechanism.
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